MedExecWomen is an organization focused on empowering female executives to accelerate the positive impact of medical devices, diagnostics, drug delivery, and digital healthcare around the world. We’re committed to: Creating a network of executive women in medtech and facilitating connections. Improving gender parity in medtech leadership positions. Educating executives about the benefits of diverse leadership...
Join industry leaders from bio/pharma manufacturers, wholesalers, GPOs and more for interactive dialogues and strategic best practices to optimize commercial contract models, maximize chargeback efficiencies and streamline eligibility management at the 23rd Annual Life Sciences Commercial Contracts and Chargebacks Conference, now part of the Pricing and Contracting USA event in Washington DC. This year’s agenda...
STAY ON THE PULSE OF FEDERAL AND STATE REPORTING REQUIREMENTS, POLICY INITIATIVES & STRATEGIC BEST PRACTICES FOR COMPLIANCE Discuss how current and future drug pricing transparency regulations will impact commercialization, reimbursement, pricing and compliance practices. Assess how companies are planning internally for these changes, hear updates impacting drug pricing transparency and gain a preview of...
Conquer the complex regulatory guidelines and evolve strategies to contract, report and comply with federal and state healthcare programs
Managing risk is a tricky business. Join us as we discuss risk management and insurance tools/strategies for early stage companies. Adequate Directors’ and officers’ (D&O) liability and Cyber insurance is critical to your success , but it can also be misunderstood Lessons learned – including what activities/ claims are covered Insurance Purchasing Milestones – securing...
Join experts from Quotient Sciences & Charles River for a webinar taking place on the 18th May at 8:30am PST | 11:30am EST | 4:30pm BST. Integrated Strategies for Accelerating from Discovery to IND and Beyond: Charles River & Quotient Sciences Collaboration The early drug development roadmap from discovery to preclinical IND and onwards can...
Psychedelics as Therapeutics: Unique Considerations for Clinical Trials Early research into the use of psychedelics as therapeutics demonstrated promise of clinical benefit across a range of neurological and psychiatric disorders. However, much of this research ended abruptly following passage of the Controlled Substances Act (CSA) in 1970 and the subsequent ‘war on drugs.’ The 21st...
Come hear the career stories, challenges, and successes of our esteemed panelists. They will share with us their personal journeys in the biopharmaceutical industry, the challenges women can expect to face, as well as general advice for women (and others) hoping to build their careers in the Industry. **Early Bird Tickets Sold Out** Genentech Visitor...
The World Orphan Drug Congress brings together leading pharmaceutical and biotech companies, government and regulatory authorities, patient advocacy groups, payers, investors and solution providers. The conference is a place to meet and brainstorm ways to advance orphan drug development and improve access to life-saving therapies. Join us for three days in Boston for the most...
SynBioBeta is the premier innovation network for biological engineers, innovators, entrepreneurs, and investors who share a passion for using biology to build a better, more sustainable planet. We provide our community members with personal and professional development support, as well as valuable opportunities for networking, partnership, collaboration, and education. Every year we host The Global Synthetic...
Networking- Providing networking opportunities for the life sciences communities in Boston and beyond. Science Showcase- Creating quarterly business showcase events for Boston life sciences entrepreneurs, executives and investors. A low-stress forum where life sciences companies can network receive feedback from accredited experts and investors during varied stages of their innovation life cycle. Showcasing life sciences companies led...
LABEST 2023 is the premiere bioscience conference in the LA Region. UCLA TDG produces the event that brings together industry, VCs, investors, researchers and partners including USC, City of Hope, Cedars-Sinai, CalTech and more. This year's event features fireside chats, keynote speakers, breakout sessions with incubators, biomanufacturers, student researchers, learning lounges, industry sponsored research and research...
